AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 |Industry: Pharmaceuticals
|Expensive Performer
3810.20 -119.10 (-3.03%)
NSE Jan 21, 2021 15:31 PM
Volume: 134.5K

Business Standard
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage amid questions over the results from its late-stage study
More from AstraZeneca Pharma India Ltd.